| Registry | NCT02551406, acronym TcCO2-VAD |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 55 (Actual) |
| Sponsor | Centre d'Investigation Clinique et Technologique 805 (Other) |
| Conditions | Home Mechanical Ventilation, Neuromuscular Disease |
| Interventions | Capno-oxymetry monitoring (Device) |
| Dates | start 2015-09-01, primary completion 2015-12-01, completion 2015-12-01, first posted 2015-09-16, last updated 2016-02-26 |
| Locations | 1 site in France |
Related Papers Related Patents Related Grants Related Experts
All trials for Home Mechanical Ventilation All trials for Neuromuscular Disease All trials of Capno-oxymetry monitoring
Different tools may be used to monitor the efficacy of home mechanical ventilation. Investigators aimed to compare the prognostic value of the different data obtained by capno-oxymetry in a mechanical ventilated neuromuscular disease's population.
Home mechanical ventilation (HMV) is used to treat hypoventilation, and its efficacy is mostly assessed by daytime blood gases and nocturnal oxymetry (SpO2). Transcutaneous CO2 measure (TcCO2) has shown higher sensitivity than SpO2 to detect hypoventilation in neuromuscular diseases (NMD) patients. No data exist on the prognostic value of these techniques to monitor mechanical ventilated NMD patients.
Basing on retrospective data review, investigators aimed to compare the prognostic value of the data obtained using different tools to assess residual hypoventilation in the cohort of ventilated NMD patients followed at our reference center.
Sex: All, ages: 18 Years to any
Inclusion Criteria: * neuromuscular disease * age ≥18 years * mechanically ventilated * capno-oxymetry performed between 2009 and 2011 Exclusion Criteria: * Long-term oxygen therapy
| Facility | City | Country | Status |
|---|---|---|---|
| Hopital Raymond Poincare | Garches, Garches | France |